U.S. Markets open in 8 hrs 42 mins

Investors are Betting Against Sangamo Biosciences, Inc. (SGMO) Should You?

Zacks Equity Research

Many investors appear to be quite bearish Sangamo Biosciences, Inc. (SGMO) especially if you look at the percentage of the float that is sold short for this stock. Currently, 20.45% of the float is sold short, suggesting an extreme level of bearishness for SGMO.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2 (Buy) on SGMO, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of SGMO to move higher in the weeks ahead.

SANGAMO BIOSCIENCES INC (SGMO): Free Stock Analysis Report

Zacks Investment Research